Diagnóstico bioquímico del exceso de secreción de prolactina

Melmed, 2003, Adenohipófisis, 1, 220 Casamitjana R. Bioquímica y características analíticas de las hormonas proteicas. En: Gaya J, Berlanga E, directores. Estudio de la función gonadal y de la fertilidad en el laboratorio clínico. Barcelona: Sociedad Española de Bioquímica Clínica y Patología Molecular; 2001. p. 27-40. Audí L. Fisiopatología del hipotálamo y la hipófisis. En: Gaya J, Berlanga E, directores. Estudio de la función gonadal y de la fertilidad en el laboratorio clínico. Barcelona: Sociedad Española de Bioquímica Clínica y Patología Molecular; 2001. p. 78-80. Noel, 1972, Human prolactin and growth hormone release during surgery and other conditions of stress, J Clin Endocrinol Metab, 35, 840, 10.1210/jcem-35-6-840 World Health Organization. Blood products and related biologicals. International reference materials [citado 27 Ene 2006]. Disponible en: http://www.who.int/bloodproducts/ref_materials Nacional Institute for Biological Standards and Control. Products [citado 27 Ene 2006]. Disponible en: http://www.nibsc.ac.uk/products/directorylist.asp Ministerio de Sanidad y Consumo. Catálogo de pruebas de los laboratorios clínicos [citado 24 Mar 2006]. Disponible en: http://www.ingesa.msc.es/estadEstudios/documPublica/memorias/pdf/catalogoa.pdf Verhelst, 2003, Hyperprolactinemia: pathophysiology and management, Treat Endocrinol, 2, 23, 10.2165/00024677-200302010-00003 Levy, 2004, Pituitary disease: presentation, diagnosis and management, J Neurol Neurosurg Psychiatry, 75, 47, 10.1136/jnnp.2004.045740 Schlechte, 2002, The macroprolactin problem [editorial], J Clin Endocrinol Metab, 87, 5408, 10.1210/jc.2002-021617 Jackson, 1985, Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses, J Clin Endocrinol Metab, 61, 258, 10.1210/jcem-61-2-258 Andersen, 1982, Bioactivity of prolactin in a woman with a excess of large molecular size prolactin, persistent hyperprolactinaemia and spontaneous conception, Fertil Steril, 38, 625, 10.1016/S0015-0282(16)46646-X Suliman, 2003, Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia, Clin Chem, 49, 1504, 10.1373/49.9.1504 Vieira, 1998, Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia, Clin Chem, 44, 1758, 10.1093/clinchem/44.8.1758 Olukoga, 1999, Macroprolactinemia: validation and application of the polyethilene glicol precipitation test and clinical characterization of the condition, Clin Endocrinol, 51, 119, 10.1046/j.1365-2265.1999.00757.x Fahie-Wilson, 1999, Polyethylene glycol precipitation as a screening method for macroprolactinemia, Clin Chem, 45, 436 Leslie, 2001, Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method, J Clin Endocrinol Metab, 86, 2743, 10.1210/jc.86.6.2743 Smith, 2002, Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by comercial immunoassays, J Clin Endocrinol Metab, 87, 5410, 10.1210/jc.2001-011943 Molitch, 1990, The pituitary “incidentaloma”, Ann Intern Med, 112, 925, 10.7326/0003-4819-112-12-925 Hauche, 2002, Screening for macroprolactinaemia and pituitary imaging studies, Clin Endocrinol, 57, 327, 10.1046/j.1365-2265.2002.01586.x Rodríguez-Espinosa, 2004, Cambios en la proporción de macroprolactina durante el seguimiento de pacientes macroprolactinémicos, Quim Clin, 23, 127 Fahie-Wilson, 2003, In hyperprolactinemia, testing for macroprolactin is essential [editorial], Clin Chem, 49, 1434, 10.1373/49.9.1434 Wallach, 1998